Retrospective Study
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Oncol. Mar 15, 2024; 16(3): 819-832
Published online Mar 15, 2024. doi: 10.4251/wjgo.v16.i3.819
T2-weighted imaging-based radiomic-clinical machine learning model for predicting the differentiation of colorectal adenocarcinoma
Hui-Da Zheng, Qiao-Yi Huang, Qi-Ming Huang, Xiao-Ting Ke, Kai Ye, Shu Lin, Jian-Hua Xu
Hui-Da Zheng, Kai Ye, Jian-Hua Xu, Department of Gastrointestinal Surgery, The Second Affiliated Hospital of Fujian Medical University, Quanzhou 362000, Fujian Province, China
Qiao-Yi Huang, Department of Gynaecology and Obstetrics, The Second Affiliated Hospital of Fujian Medical University, Quanzhou 362000, Fujian Province, China
Qi-Ming Huang, Xiao-Ting Ke, Department of Computed Tomography/Magnetic Resonance Imaging, The Second Affiliated Hospital of Fujian Medical University, Quanzhou 362000, Fujian Province, China
Shu Lin, Centre of Neurological and Metabolic Research, The Second Affiliated Hospital of Fujian Medical University, Quanzhou 362000, Fujian Province, China
Shu Lin, Group of Neuroendocrinology, Garvan Institute of Medical Research, Sydney, NSW 2010, Australia
Co-corresponding authors: Shu Lin and Jian-Hua Xu.
Author contributions: Zheng HD and Huang QY provided the concept and designed; Zheng HD, Huang QM and Ke XT performed image interpretation and segmentation; Xu JH, Lin S and Ye K provided clinical advice, reviewed the manuscript and gave final approval of the version of the article to be published; Xu JH and Lin S contributed equally to this work as co-corresponding authors. The study was completed with the participation of multiple members, and the designation of the co-corresponding author accurately reflected the allocation of responsibilities and burdens related to the time and effort required to complete the study and the resulting paper. Xu JH and Lin S both gave great help in the study process. Because the study belongs to clinical study, the corresponding authors provided a large number of clinical opinions, reviewed the manuscript in detail and carefully, and finally approved the publication of the manuscript. These researchers were selected as co-corresponding authors, recognizing and respecting this equal contribution. In conclusion, we think it is appropriate to designate Xu JH and Lin S as the co-corresponding authors, because this can reflect the actual contributions of these authors.
Supported by the Fujian Province Clinical Key Specialty Construction Project, No. 2022884; Quanzhou Science and Technology Plan Project, No. 2021N034S; The Youth Research Project of Fujian Provincial Health Commission, No. 2022QNA067; Malignant Tumor Clinical Medicine Research Center, No. 2020N090s.
Institutional review board statement: The study was reviewed and approved for publication by Institutional Reviewer of The Second Affiliated Hospital of Fujian Medical University (No. 2023-429).
Informed consent statement: As the study used anonymous and pre-existing data, the requirement for the informed consent from patients was waived.
Conflict-of-interest statement: All the Authors have no conflict of interest related to the manuscript.
Data sharing statement: The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Jian-Hua Xu, MD, Chief Physician, Dean, Research Dean, Surgeon, Surgical Oncologist, Department of Gastrointestinal Surgery, The Second Affiliated Hospital of Fujian Medical University, No. 950 Donghai Street, Fengze District, Quanzhou 362000, Fujian Province, China. xjh630913@126.com
Received: October 9, 2023
Peer-review started: October 9, 2023
First decision: December 6, 2023
Revised: December 30, 2023
Accepted: January 29, 2024
Article in press: January 29, 2024
Published online: March 15, 2024
Processing time: 154 Days and 20.2 Hours
ARTICLE HIGHLIGHTS
Research background

Magnetic resonance imaging (MRI) is an important technology for the preoperative evaluation of colorectal cancer (CRC). At present, studies on predicting the differentiation grade of CRC based on MRI are lacking. The development of a noninvasive and accurate preoperative prediction method for evaluating the differentiation grade of disease in CRC patients is highly important for individualized treatment.

Research motivation

Due to tumour heterogeneity, colonoscopy biopsy has limitations in evaluating the differentiation grade of CRC. The prospect of creating an accurate radiomics-based system for differentiating the grade of CRC and facilitating prognosis prediction warrants investigation.

Research objectives

In this study, we sought to construct a prediction model based on radiomic and clinical factors for accurately predicting the differentiation grade of CRC patients.

Research methods

The enhanced MRI data and clinical information of 315 patients with CRC were collected and analyzed, and a machine learning algorithm was developed based on the extracted radiomic features and important clinical features. Each model was evaluated, and the best model was selected. The performance of the model was evaluated by receiver operating characteristic curve, calibration curve and decision curve analyses.

Research results

In this study, eight radiomic features were selected from enhanced MRI, and eight models were constructed based on a machine learning algorithm. The multilayer perceptron (MLP) algorithm showed the best performance, with an area under the curve (AUC) of 0.796 (95%CI: 0.723-0.869) in the training cohort and 0.735 (95%CI: 0.604-0.866) in the validation cohort. Radiomics features were combined with N stage, tumour occupying intestinal circumference, nerve invasion, and vascular invasion to develop a radiomic-clinical model. The AUC of the radiomic-clinical model was 0.862 (95%CI: 0.796-0.927) in the training cohort and 0.761 (95%CI: 0.635-0.887) in the validation cohort.

Research conclusions

The model based on the MLP algorithm is helpful for providing individualized differentiation grade assessment for CRC patients.

Research perspectives

The radiomic-clinical prediction model constructed in this study is helpful for evaluating the differentiation grade and prognosis of CRC patients, and a prospective multicentre trial will help to improve the performance of the model.